- Home
- TRMK vs IRON Comparison
TRMK vs IRON Comparison
Compare TRMK & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- IRON
- Stock Information
- Founded
- TRMK 1889
- IRON 2017
- Country
- TRMK United States
- IRON United States
- Employees
- TRMK N/A
- IRON N/A
- Industry
- TRMK Major Banks
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- TRMK Finance
- IRON Health Care
- Exchange
- TRMK Nasdaq
- IRON Nasdaq
- Market Cap
- TRMK 2.3B
- IRON 2.0B
- IPO Year
- TRMK 1987
- IRON N/A
- Fundamental
- Price
- TRMK $39.15
- IRON $60.72
- Analyst Decision
- TRMK Buy
- IRON Strong Buy
- Analyst Count
- TRMK 4
- IRON 12
- Target Price
- TRMK $41.00
- IRON $92.08
- AVG Volume (30 Days)
- TRMK 304.2K
- IRON 389.8K
- Earning Date
- TRMK 07-22-2025
- IRON 08-07-2025
- Dividend Yield
- TRMK 2.45%
- IRON N/A
- EPS Growth
- TRMK 17.82
- IRON N/A
- EPS
- TRMK 3.56
- IRON N/A
- Revenue
- TRMK $758,379,000.00
- IRON N/A
- Revenue This Year
- TRMK $58.78
- IRON N/A
- Revenue Next Year
- TRMK $4.52
- IRON N/A
- P/E Ratio
- TRMK $10.99
- IRON N/A
- Revenue Growth
- TRMK 58.50
- IRON N/A
- 52 Week Low
- TRMK $29.77
- IRON $30.82
- 52 Week High
- TRMK $40.73
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- TRMK 60.10
- IRON 59.60
- Support Level
- TRMK $36.35
- IRON $56.44
- Resistance Level
- TRMK $39.34
- IRON $61.63
- Average True Range (ATR)
- TRMK 0.71
- IRON 1.93
- MACD
- TRMK 0.10
- IRON -0.18
- Stochastic Oscillator
- TRMK 82.52
- IRON 82.47
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.